226 related articles for article (PubMed ID: 32979343)
1. Nanoparticles based therapeutic efficacy against Acanthamoeba: Updates and future prospect.
Sharma G; Kalra SK; Tejan N; Ghoshal U
Exp Parasitol; 2020 Nov; 218():108008. PubMed ID: 32979343
[TBL] [Abstract][Full Text] [Related]
2. Tannic acid-modified silver nanoparticles as a novel therapeutic agent against Acanthamoeba.
Padzik M; Hendiger EB; Chomicz L; Grodzik M; Szmidt M; Grobelny J; Lorenzo-Morales J
Parasitol Res; 2018 Nov; 117(11):3519-3525. PubMed ID: 30112674
[TBL] [Abstract][Full Text] [Related]
3. Metformin-coated silver nanoparticles exhibit anti-acanthamoebic activities against both trophozoite and cyst stages.
Anwar A; Soomaroo A; Anwar A; Siddiqui R; Khan NA
Exp Parasitol; 2020 Aug; 215():107915. PubMed ID: 32461112
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and in vitro activity of new biguanide-containing dendrimers on pathogenic isolates of Acanthamoeba polyphaga and Acanthamoeba griffini.
Martín-Pérez T; Lozano-Cruz T; Criado-Fornelio A; Ortega P; Gómez R; de la Mata FJ; Pérez-Serrano J
Parasitol Res; 2019 Jun; 118(6):1953-1961. PubMed ID: 31069536
[TBL] [Abstract][Full Text] [Related]
5. Amoebicidal activities of alexidine against 3 pathogenic strains of acanthamoeba.
Alizadeh H; Neelam S; Cavanagh HD
Eye Contact Lens; 2009 Jan; 35(1):1-5. PubMed ID: 19125040
[TBL] [Abstract][Full Text] [Related]
6. The Development of Drugs against Acanthamoeba Infections.
Siddiqui R; Aqeel Y; Khan NA
Antimicrob Agents Chemother; 2016 Nov; 60(11):6441-6450. PubMed ID: 27600042
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial effect of auranofin against Acanthamoeba spp.
Loufouma Mbouaka A; Leitsch D; Koehsler M; Walochnik J
Int J Antimicrob Agents; 2021 Nov; 58(5):106425. PubMed ID: 34419578
[TBL] [Abstract][Full Text] [Related]
8. Oleic acid-conjugated silver nanoparticles as efficient antiamoebic agent against Acanthamoeba castellanii.
Anwar A; Abdalla SAO; Aslam Z; Shah MR; Siddiqui R; Khan NA
Parasitol Res; 2019 Jul; 118(7):2295-2304. PubMed ID: 31093751
[TBL] [Abstract][Full Text] [Related]
9. Voriconazole as a first-line treatment against potentially pathogenic Acanthamoeba strains from Peru.
Cabello-Vílchez AM; Martín-Navarro CM; López-Arencibia A; Reyes-Batlle M; Sifaoui I; Valladares B; Piñero JE; Lorenzo-Morales J
Parasitol Res; 2014 Feb; 113(2):755-9. PubMed ID: 24265059
[TBL] [Abstract][Full Text] [Related]
10. Drugs used for the treatment of cerebral and disseminated infections caused by free-living amoebae.
Taravaud A; Fechtali-Moute Z; Loiseau PM; Pomel S
Clin Transl Sci; 2021 May; 14(3):791-805. PubMed ID: 33650319
[TBL] [Abstract][Full Text] [Related]
11. Persistently culture positive acanthamoeba keratitis: in vivo resistance and in vitro sensitivity.
Pérez-Santonja JJ; Kilvington S; Hughes R; Tufail A; Matheson M; Dart JK
Ophthalmology; 2003 Aug; 110(8):1593-600. PubMed ID: 12917179
[TBL] [Abstract][Full Text] [Related]
12. Cobalt nanoparticles as novel nanotherapeutics against Acanthamoeba castellanii.
Anwar A; Numan A; Siddiqui R; Khalid M; Khan NA
Parasit Vectors; 2019 Jun; 12(1):280. PubMed ID: 31159839
[TBL] [Abstract][Full Text] [Related]
13. [Amebicidal plants extracts].
Derda M; Hadaś E; Thiem B; Sułek A
Wiad Parazytol; 2004; 50(4):715-21. PubMed ID: 16862806
[TBL] [Abstract][Full Text] [Related]
14. The reculture technique: individualizing the treatment of Acanthamoeba keratitis.
Wysenbeek YS; Blank-Porat D; Harizman N; Wygnanski-Jaffe T; Keller N; Avni I
Cornea; 2000 Jul; 19(4):464-7. PubMed ID: 10928758
[TBL] [Abstract][Full Text] [Related]
15. Effects of lactoferrin on the viability and the encystment of Acanthamoeba trophozoites.
Tomita S; Suzuki C; Wada H; Nomachi M; Imayasu M; Araki-Sasaki K
Biochem Cell Biol; 2017 Feb; 95(1):48-52. PubMed ID: 28140621
[TBL] [Abstract][Full Text] [Related]
16. Artemether Exhibits Amoebicidal Activity against Acanthamoeba castellanii through Inhibition of the Serine Biosynthesis Pathway.
Deng Y; Ran W; Man S; Li X; Gao H; Tang W; Tachibana H; Cheng X
Antimicrob Agents Chemother; 2015 Aug; 59(8):4680-8. PubMed ID: 26014935
[TBL] [Abstract][Full Text] [Related]
17. Acanthamoeba and its pathogenic role in granulomatous amebic encephalitis.
Kalra SK; Sharma P; Shyam K; Tejan N; Ghoshal U
Exp Parasitol; 2020 Jan; 208():107788. PubMed ID: 31647916
[TBL] [Abstract][Full Text] [Related]
18. In vitro anti-Acanthamoeba synergistic effect of chlorhexidine and cationic carbosilane dendrimers against both trophozoite and cyst forms.
Heredero-Bermejo I; Sánchez-Nieves J; Soliveri J; Gómez R; de la Mata FJ; Copa-Patiño JL; Pérez-Serrano J
Int J Pharm; 2016 Jul; 509(1-2):1-7. PubMed ID: 27173821
[TBL] [Abstract][Full Text] [Related]
19. In vitro efficacy of corifungin against Acanthamoeba castellanii trophozoites and cysts.
Debnath A; Tunac JB; Silva-Olivares A; Galindo-Gómez S; Shibayama M; McKerrow JH
Antimicrob Agents Chemother; 2014; 58(3):1523-8. PubMed ID: 24366747
[TBL] [Abstract][Full Text] [Related]
20. Antiamoebic activity of synthetic tetrazoles against Acanthamoeba castellanii belonging to T4 genotype and effects of conjugation with silver nanoparticles.
Anwar A; Yi YP; Fatima I; Khan KM; Siddiqui R; Khan NA; Anwar A
Parasitol Res; 2020 Jun; 119(6):1943-1954. PubMed ID: 32385711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
